Dec 6 2010
Executives from Phytopharm Plc (Huntingdon,UK) signed an agreement with O2h (Cambridge, UK, Ahmedabad, India) under which O2h will provide chemistry and ADME services to support drug discovery initiatives at Phytopharm.
Tim Sharpington, CEO of Phytopharm said "I have known O2h for a number of years and am aware of their extensive experience of providing chemistry and ADME support to virtual companies around the world. I look forward to this opportunity of working with them to advance our drug discovery pipeline."
"O2h has its roots in Cambridge, UK and has grown with support from the UK biotech sector to help accelerate drug discovery efforts of companies in USA, EU and Japan. It is our privilege to work with the experienced team led by Tim Sharpington, at Phytopharm." - Sunil Shah, CEO, O2h.